Skip to main content
GIPResearch.com · Patent and Technology Research

Dompe Farmaceutici S.P.A Received a Patent for Phenylpropionic Derivatives

Dompe Farmaceutici SpA operates as a holding company in the pharmaceutical industry.

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
Conceptual GIPResearch illustration for Dompe Farmaceutici S.P.A Received a Patent for Phenylpropionic Derivatives
Research and original publication material

Dompe Farmaceutici S.P.A Received a Patent for Phenylpropionic Derivatives — research background

Research context: This article preserves existing publication material for continuity. Technical, commercial and legal references should be checked against current primary sources before making decisions.

Dompe Farmaceutici SpA operates as a holding company in the pharmaceutical industry. The Company provides administration, finance, control, compliance, and human resource management for its operating subsidiaries. Dompe Farmaceutici, through its subsidiaries, conducts medical and genetic research for the global healthcare markets. Dompe Farmaceutici S.P.A filed patent application numbered 2082/CHENP/2010 that is titled  (R)-4-(HETEROARYL) PHENYLPROPIONIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. This patent application has been granted as Patent Number 299768. The invention covers Chemical compounds. The present invention relates to a novel class of (R)-4-(heteroaryl) phenylpropionic derivatives of formula (I), useful in the inhibition of chemotactic activation included by the fraction C5a of complement. Said compounds are useful in the treatment of pathologies depending on the chemotactic activation of neutrophils and monocytes induced by the fraction C5a of the complement. During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act, wherein the examiner stated that the Claim(s) 1-10  are statutorily non-patentable and are mere modifications.  As a response to said objection, the applicant responded by submitting technical and scientific arguments. Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter. Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech). Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.

Discuss a research question related to Dompe Farmaceutici S.P.A Received a Patent for

Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.

Discuss a research question

Source and context: Original GIPResearch.com publication dated 2019-08-27. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.

None

Featured Work & Insights